Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NUVL
NUVL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NUVL News
Wohl & Fruchter Investigates Fairness of Nuvalent Sale to GSK
3d ago
Globenewswire
Investors' Rights Investigation and Potential Violations
3d ago
Globenewswire
Biotech IPO Market Reopens Amid M&A Surge
3d ago
CNBC
Biotech Investors Become More Selective Amid Market Changes
3d ago
Newsfilter
Investor Rights Law Firm Investigates Multiple Companies
4d ago
Globenewswire
Investigation Alerts for Multiple Mergers
4d ago
Globenewswire
Biotech Sector Sees Surge in FDA and Global Approvals
Jun 12 2026
NASDAQ.COM
Investor Rights Law Firm Investigates Multiple Companies
Jun 12 2026
PRnewswire
GSK's $10.6 Billion Nuvalent Acquisition to Rebuild Cancer Drug Portfolio
Jun 11 2026
Newsfilter
Ademi LLP Investigates Nuvalent's Transaction Compliance
Jun 10 2026
PRnewswire
UK Tech Ecosystem Rebounds with New Growth
Jun 10 2026
CNBC
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
Jun 10 2026
Globenewswire
US Stocks Close: Nasdaq Hits 5-Week Low Amid Market Rotations
Jun 09 2026
NASDAQ.COM
Tech Stocks Retreat as DraftKings Soars on SEC Filing
Jun 09 2026
CNBC
US Stock Market Volatility Amid Falling WTI Crude Prices
Jun 09 2026
NASDAQ.COM
Investor Alert: Investigations into Multiple Mergers
Jun 09 2026
Globenewswire
Show More News
